CNBC's Jim Cramer said Monday that investors shouldn't fear the latest market rotation. Instead, he thinks it's creating buying opportunities in several high-quality stocks...
Trump on who's his favorite president: 'We've had some very bad presidents'President Donald Trump speaks with CNBC’s Joe Kernen in the Oval Office of...
Moderna's expanding pipeline beyond infectious diseases is giving investors a new reason to own the stock after years of uncertainty following the Covid-19 pandemic,...
Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for a pilot program designed to accelerate...
Brian Cornell, Executive Chairman of the Target Corporation.Anjali Sundaram | CNBCTarget has promised investors that it's pursuing an aggressive turnaround with a new CEO...
Thomas Fuller | SOPA Images | Lightrocket | Getty ImagesUniQure plans to seek FDA approval of its experimental gene therapy for Huntington's disease, the...
Sheldon Cooper | Lightrocket | Getty ImagesCentene said it offered buyouts to some employees on Monday, as the health insurer grapples with higher medical...
Nikolas Kokovlis | Nurphoto | Getty ImagesA version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news...
